|
(Reuters) - Venture capital dealmaking in the United States
reached an all-time high in 2021 at nearly $330 billion, buoyed
by excess liquidity and an accommodative monetary policy,
according to a report from PitchBook and the National Venture
Capital Association.
Venture capital firms ramped up bets on technology, biotech,
healthcare and fintech sectors, announcing a record 17,054 deals
in the year.
It was also the best year on record for VC fundraising, which
hit $128.3 billion across 730 funds. The figure, which breached
the $100 billion-mark for the first time, was $40 billion higher
than the previous record in 2020.
For an interactive graphic, click on this link: https://tmsnrt.rs/3Gp0ybS
Graphic: U.S. venture capital deals activity, https://tmsnrt.rs/3r8WSUY
Some of the biggest fundraises last year included crypto firm
FTX Trading, which was valued at $25 billion in October, and AI
platform Databricks, which notched a valuation of $38 billion in
August, each raising $1 billion.
The frenetic pace of fund raising is expected to continue this
year, as cash with venture capital firms remains at an all-time
high, and returns outpace all other assets classes, the report
added.
VC-backed companies going public or being bought out led to
exits worth $774.1 billion in 2021, nearly 88% of which was
realized through public listings. While the U.S. initial public
offering (IPO) market continued on a tear, special purpose
acquisition companies have offered a viable alternative to IPOs
despite tightening regulatory scrutiny.
(Reporting by Niket Nishant and Sohini Podder in Bengaluru;
Editing by Vinay Dwivedi)
[© 2022 Thomson Reuters. All rights
reserved.]
This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|
